Mulberry Developments acquires GlaxoSmithKline site in Harlow

Mulberry Property Developments (Mulberry Developments) is┬ápleased to announce the successful acquisition of the former GlaxoSmithKline South site in Harlow, Essex. The site extends to 44.6 acres and includes approximately 326,704 sq ft of industrial/R&D space, which has been leased back to GlaxoSmithKline. With approximately 29 acres available for a new industrial/logistics/data centre development – subject…